Cyient DLM (CYIENTDLM) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
10 Sep, 2026Executive summary
Completed the acquisition and integration of Altek Electronics LLC, USA, for $19.9 million, expanding U.S. manufacturing presence and diversifying sector exposure to industrial and medical segments, with Altek contributing $10.24 million in revenue and $0.63 million in profit before tax since acquisition.
Q3 FY25 results include Altek for the first time, with synergy discussions and revenue opportunities expected to materialize in coming quarters.
Added a new global technology client in Q3 and maintained a pipeline exceeding $1Bn in total contract value.
Recognized with the STPI IT Export Award and Karnataka state award for export and business growth.
Reported unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2024, reviewed and approved by the Board and auditors without qualification.
Financial highlights
Consolidated Q3 FY25 revenue reached INR 4,442.36 million, up 38.4% year-on-year; nine-month revenue was INR 10,915.71 million, up 31.5% year-on-year.
Adjusted EBITDA was INR 359 million (8.1% margin), up 21.9% year-on-year; reported EBITDA was INR 279 million (6.3% margin) after one-time M&A expenses.
Adjusted PAT was INR 166 million (3.7% margin), down 9.8% year-on-year; reported PAT was INR 108 million (2.4% margin).
Order backlog stands at INR 21,429 million, including INR 291.5 crores from Altek.
Free cash flow was positive for the quarter, aided by working capital improvements and Altek's contribution, with consolidated free cash flow at INR 478 million.
Outlook and guidance
Expecting higher growth in North America due to Altek acquisition and U.S. localization policies, with further growth anticipated in US Defense, Industrial, and Medical sectors.
Margin improvement anticipated in Q4 as low-margin business ramps down; full-year margin expected to be flat year-over-year, with a target to consistently deliver 10% EBITDA margin.
Revenue CAGR guidance remains at 30% over the mid-to-long term, though annual variability is expected.
M&A integration expenses of INR 80 million in Q3 are one-time and not expected to recur.
First half of next year may be soft, but margin improvement is expected for the full year.
Latest events from Cyient DLM
- Q2 FY25 revenue up 33.4% YoY, with Altek acquisition boosting US growth and future EPS.CYIENTDLM
Q2 24/25 - Q4 FY25 saw record margins and growth, led by Altek integration and US expansion.CYIENTDLM
Q4 24/25 - Revenue and EBITDA grew with record order intake, but PAT and EPS declined YoY.CYIENTDLM
Q1 25/26 - Q2 FY26 order intake and PAT surged despite revenue decline, with growth expected from Q4.CYIENTDLM
Q2 25/26 - Q3 FY26 revenue fell 31.7% YoY, but EBITDA margin rose to 10.2% with a strong order backlog.CYIENTDLM
Q3 25/26 - FY26 ended with record order book, improved margins, and strong profit despite revenue volatility.CYIENTDLM
Q4 25/26 - Record revenue and profit growth, robust order book, and expansion into AI and robotics.CYIENTDLM
Q1 26/27